Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2018-06-07
2018-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improved Oral Bioavailability of Curcumin Incorporated Into Micelles
NCT01982734
A Comparative Pharmacokinetic Study to Evaluate the Ability of a New Formulation to Enhance Curcuminoids Bioavailability
NCT03621865
Oral Bioavailability of Curcumin From Micronized Powder and Liquid Micelles in Healthy Young Women and Men
NCT01925287
Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
NCT07196514
Single Oral Dose Comparative Bioavailability Study of Investigational Product in Healthy Human Subjects Under Fasting Conditions.
NCT07141368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Native turmeric extract
6 capsules of native curcumin (207 mg curcumin)
Native turmeric extract
207 mg curcumin
Native turmeric extract with 7-9% volatile turmeric oils
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Native turmeric extract with 7-9% volatile turmeric oils
207 mg curcumin
Turmeric extract plus mixture of phytochemicals
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Turmeric extract plus mixture of phytochemicals
207 mg curcumin
Cyclodextrin complex of curcuminoids
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Cyclodextrin complex of curcuminoids
207 mg curcumin
Turmeric oleoresin
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Turmeric oleoresin
207 mg curcumin
Liposomal curcumin
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Liposomal curcumin
207 mg curcumin
Phytosomal curcumin
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Phytosomal curcumin
207 mg curcumin
Micellar turmeric extract
6 capsules of the formulation; dosage normalized to 207 mg curcumin
Micellar turmeric extract
207 mg curcumin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Native turmeric extract
207 mg curcumin
Native turmeric extract with 7-9% volatile turmeric oils
207 mg curcumin
Turmeric extract plus mixture of phytochemicals
207 mg curcumin
Cyclodextrin complex of curcuminoids
207 mg curcumin
Turmeric oleoresin
207 mg curcumin
Liposomal curcumin
207 mg curcumin
Phytosomal curcumin
207 mg curcumin
Micellar turmeric extract
207 mg curcumin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index in a normal range
Exclusion Criteria
* Alcohol and or drug abuse
* Use of dietary supplements or any medications except contraceptives
* Any known malignant, metabolic and endocrine diseases
* Previous cardiac infarction
* Dementia
* Blood pressure \>140/90 mmHg
* Resting heart rate not within 50 to 90 beats per minute
* Participation in a clinical trial within the past 6 weeks
* Smoking
* Physical activity of more than 5 h per wk
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hohenheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Frank, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Hohenheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Hohenheim
Stuttgart, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of the research group
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-CUV-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.